This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: Brock University, National Research Council of Canada. Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 27 
2 out of 1,039 Years Active: 2013-2019
Title: The Innovations of Hongbin Yan
Introduction
Hongbin Yan is a notable inventor based in St. Catharines, Canada. He has made significant contributions to the field of vaccine development, particularly through his innovative use of fluorinated cyclic dinucleotides. With a total of 3 patents to his name, Yan's work has the potential to enhance the effectiveness of oral vaccines.
Latest Patents
Hongbin Yan's latest patents focus on the use of fluorinated cyclic dinucleotides as oral vaccine adjuvants. These patents disclose the application of fluorinated cyclic dinucleotides and their pharmaceutically acceptable salts as adjuvants for the preparation of oral vaccines. Furthermore, they highlight the ability of these compounds to enhance the immune response to vaccines administered orally.
Career Highlights
Throughout his career, Hongbin Yan has worked with esteemed institutions such as Brock University and the National Research Council of Canada. His research has been pivotal in advancing the understanding of vaccine adjuvants and their role in immunology.
Collaborations
Some of his notable coworkers include Wangxue Chen and Rhonda Kuo Lee. Their collaborative efforts have contributed to the success of his research and innovations.
Conclusion
Hongbin Yan's work exemplifies the intersection of innovation and healthcare, particularly in the realm of vaccine development. His contributions are poised to make a lasting impact on the field of immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile